194 related articles for article (PubMed ID: 34140348)
1. Breast-Specific Molecular Clocks Comprised of
Miyano M; Sayaman RW; Shalabi SF; Senapati P; Lopez JC; Angarola BL; Hinz S; Zirbes A; Anczukow O; Yee LD; Sedrak MS; Stampfer MR; Seewaldt VL; LaBarge MA
Cancer Prev Res (Phila); 2021 Aug; 14(8):779-794. PubMed ID: 34140348
[TBL] [Abstract][Full Text] [Related]
2. Lineage specific methylation of the Elf5 promoter in mammary epithelial cells.
Lee HJ; Hinshelwood RA; Bouras T; Gallego-Ortega D; Valdés-Mora F; Blazek K; Visvader JE; Clark SJ; Ormandy CJ
Stem Cells; 2011 Oct; 29(10):1611-9. PubMed ID: 21823211
[TBL] [Abstract][Full Text] [Related]
3. ELF5 inhibits the proliferation and invasion of breast cancer cells by regulating CD24.
Qu X; Li Q; Tu S; Yang X; Wen W
Mol Biol Rep; 2021 Jun; 48(6):5023-5032. PubMed ID: 34146197
[TBL] [Abstract][Full Text] [Related]
4. Single CpG hypermethylation, allele methylation errors, and decreased expression of multiple tumor suppressor genes in normal body cells of mutation-negative early-onset and high-risk breast cancer patients.
Böck J; Appenzeller S; Haertle L; Schneider T; Gehrig A; Schröder J; Rost S; Wolf B; Bartram CR; Sutter C; Haaf T
Int J Cancer; 2018 Sep; 143(6):1416-1425. PubMed ID: 29659014
[TBL] [Abstract][Full Text] [Related]
5. E74-like Factor 5 Promoter Methylation in Circulating Tumor DNA as a Potential Prognostic Marker in Breast Cancer Patients.
Salimi M; Rastegarpouyani S
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4035-4041. PubMed ID: 38156835
[TBL] [Abstract][Full Text] [Related]
6. ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer.
Kalyuga M; Gallego-Ortega D; Lee HJ; Roden DL; Cowley MJ; Caldon CE; Stone A; Allerdice SL; Valdes-Mora F; Launchbury R; Statham AL; Armstrong N; Alles MC; Young A; Egger A; Au W; Piggin CL; Evans CJ; Ledger A; Brummer T; Oakes SR; Kaplan W; Gee JM; Nicholson RI; Sutherland RL; Swarbrick A; Naylor MJ; Clark SJ; Carroll JS; Ormandy CJ
PLoS Biol; 2012; 10(12):e1001461. PubMed ID: 23300383
[TBL] [Abstract][Full Text] [Related]
7. Tissue specific DNA methylation in normal human breast epithelium and in breast cancer.
Avraham A; Cho SS; Uhlmann R; Polak ML; Sandbank J; Karni T; Pappo I; Halperin R; Vaknin Z; Sella A; Sukumar S; Evron E
PLoS One; 2014; 9(3):e91805. PubMed ID: 24651077
[TBL] [Abstract][Full Text] [Related]
8. C1orf106, an innate immunity activator, is amplified in breast cancer and is required for basal-like/luminal progenitor fate decision.
Ma J; Liu C; Yang D; Song J; Zhang J; Wang T; Wang M; Xu W; Li X; Ding S; Zhan J; Zhang H
Sci China Life Sci; 2019 Sep; 62(9):1229-1242. PubMed ID: 31376015
[TBL] [Abstract][Full Text] [Related]
9. ELF5 isoform expression is tissue-specific and significantly altered in cancer.
Piggin CL; Roden DL; Gallego-Ortega D; Lee HJ; Oakes SR; Ormandy CJ
Breast Cancer Res; 2016 Jan; 18(1):4. PubMed ID: 26738740
[TBL] [Abstract][Full Text] [Related]
10. Methylation of progesterone receptor isoform A promoter in normal breast tissue: An epigenetic link between early age at menarche and risk of breast cancer?
Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Nariman-Saleh-Fam Z; Bastami M; Saadatian Z; Zendehbad Z; Tavakkoly-Bazzaz J
J Cell Biochem; 2019 Aug; 120(8):12393-12401. PubMed ID: 30816620
[TBL] [Abstract][Full Text] [Related]
11. BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers.
Vos S; Moelans CB; van Diest PJ
Breast Cancer Res; 2017 May; 19(1):64. PubMed ID: 28569220
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of Elf5 is associated with epithelial-mesenchymal transition in urothelial cancer.
Wu B; Cao X; Liang X; Zhang X; Zhang W; Sun G; Wang D
PLoS One; 2015; 10(1):e0117510. PubMed ID: 25629735
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland.
Escamilla-Hernandez R; Chakrabarti R; Romano RA; Smalley K; Zhu Q; Lai W; Halfon MS; Buck MJ; Sinha S
BMC Mol Biol; 2010 Sep; 11():68. PubMed ID: 20831799
[TBL] [Abstract][Full Text] [Related]
14. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients.
Martínez-Galán J; Torres-Torres B; Núñez MI; López-Peñalver J; Del Moral R; Ruiz De Almodóvar JM; Menjón S; Concha A; Chamorro C; Ríos S; Delgado JR
BMC Cancer; 2014 Feb; 14():59. PubMed ID: 24495356
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
16. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
17. ELF5: A Molecular Clock for Breast Aging and Cancer Susceptibility.
Miyano M; LaBarge MA
Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275872
[TBL] [Abstract][Full Text] [Related]
18. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
[TBL] [Abstract][Full Text] [Related]
19. High-Resolution Bisulfite-Sequencing of Peripheral Blood DNA Methylation in Early-Onset and Familial Risk Breast Cancer Patients.
Chen J; Haanpää MK; Gruber JJ; Jäger N; Ford JM; Snyder MP
Clin Cancer Res; 2019 Sep; 25(17):5301-5314. PubMed ID: 31175093
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Changes of the ESR1 Gene in Breast Tissue of Healthy Women: A Missing Link with Breast Cancer Risk Factors?
Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Bastami M; Tavakkoly-Bazzaz J
Genet Test Mol Biomarkers; 2017 Aug; 21(8):464-470. PubMed ID: 28708432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
